Manara - Qatar Research Repository
Browse

The genetic basis and the diagnostic yield of genetic testing related to nonsyndromic hearing loss in Qatar

Download (1.26 MB)
journal contribution
submitted on 2025-07-07, 08:14 and posted on 2025-07-07, 08:15 authored by Shaza Alkhidir, Karen El-Akouri, Nader Al-Dewik, Houssein Khodjet-El-khil, Sarah Okashah, Nazmul Islam, Tawfeg Ben-Omran, Mashael Al-Shafai
<p dir="ltr">Hearing loss is the most predominant sensory defect occurring in pediatrics, of which, 66% cases are attributed to genetic factors. The prevalence of hereditary hearing loss increases in consanguineous populations, and the prevalence of hearing loss in Qatar is 5.2%. We aimed to investigate the genetic basis of nonsyndromic hearing loss (NSHL) in Qatar and to evaluate the diagnostic yield of different genetic tests available. A retrospective chart review was conducted for 59 pediatric patients with NSHL referred to the Department of Adult and Pediatric Medical Genetics at Hamad Medical Corporation in Qatar, and who underwent at least one genetic test. Out of the 59 patients, 39 were solved cases due to 19 variants in 11 genes and two copy number variants that explained the NSHL phenotype. Of them 2 cases were initially uncertain and were reclassified using familial segregation. Around 36.8% of the single variants were in <i>GJB2</i> gene and c.35delG was the most common recurrent variant seen in solved cases. We detected the c.283C > T variant in <i>FGF3</i> that was seen in a Qatari patient and found to be associated with NSHL for the first time. The overall diagnostic yield was 30.7%, and the diagnostic yield was significantly associated with genetic testing using <i>GJB2</i> sequencing and using the hearing loss (HL) gene panel. The diagnostic yield for targeted familial testing was 60% (n = 3 patients) and for gene panel was 50% (n = 5). Thus, we recommend using <i>GJB2</i> gene sequencing as a first-tier genetic test and HL gene panel as a second-tier genetic test for NSHL. Our work provided new insights into the genetic pool of NSHL among Arabs and highlights its unique diversity, this is believed to help further in the diagnostic and management options for NSHL Arab patients.</p><h2>Other Information</h2><p dir="ltr">Published in: Scientific Reports<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1038/s41598-024-52784-z" target="_blank">https://dx.doi.org/10.1038/s41598-024-52784-z</a></p>

Funding

Open Access funding provided by the Qatar National Library.

History

Language

  • English

Publisher

Springer Nature

Publication Year

  • 2024

License statement

This Item is licensed under the Creative Commons Attribution 4.0 International License.

Institution affiliated with

  • Hamad Medical Corporation
  • Sidra Medicine
  • Qatar University
  • Qatar University Health - QU
  • College of Health Sciences - QU HEALTH
  • Biomedical Research Center - QU

Geographic coverage

Qatar

Usage metrics

    Hamad Medical Corporation

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC